- Filed
- Feb 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 12, 2026 | 7.15M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 12.24M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 10.81M sh |
| Shares Diluted restated | Q3 2026 · Dec 31, 2024 | 111.18K sh |
| Shares Diluted restated | Q3 2026 · Dec 31, 2024 | 70.33K sh |
| Capex | Q3 2026 · Dec 31, 2025 | $3.92K |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | −$1.31M |
| Operating Cash Flow restated | Q3 2026 · Dec 31, 2024 | −$5.04M |
| Short Term Debt | Q3 2026 · Dec 31, 2025 | $2.26M |
| Short Term Debt | Q3 2026 · Mar 31, 2025 | $2.85M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $208.18K |
| Cash And Equivalents | Q3 2026 · Dec 31, 2024 | $4.4M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$27.43M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | −$27.72M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$26.8M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$25.35M |
| Stockholders Equity restated | Q3 2026 · Dec 31, 2024 | −$38.42M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | −$32.76M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | −$31.47M |
| Stockholders Equity restated | Q3 2026 · Mar 31, 2024 | −$33.69M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $29.19M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $29.51M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $30.2M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $30.71M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $909.92K |
| Current Assets | Q3 2026 · Mar 31, 2025 | $3.01M |
| Total Assets | Q3 2026 · Dec 31, 2025 | $2.77M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $5.36M |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$0.06 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$0.53 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | −$71.26 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | −$196.31 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$0.06 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$0.53 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | −$71.26 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | −$196.31 |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $678.55K |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $2.12M |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $749.29K |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $2.39M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$721.47K |
| Net Income | Q3 2026 · Dec 31, 2025 | −$5.72M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$794.15K |
| Net Income | Q3 2026 · Jun 30, 2025 | −$4.21M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$7.92M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$13.81M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$3.35M |
| Net Income | Q3 2026 · Jun 30, 2024 | −$2.53M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$1.47M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$5.22M |
| Operating Income | Q3 2026 · Dec 31, 2024 | −$3.24M |
| Operating Income | Q3 2026 · Dec 31, 2024 | −$8.18M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $1.08M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $3.59M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $1.5M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $4.22M |